Outlook Therapeutics Shares Are Trading Higher After BTIG Upgraded the Stock From Neutral to Buy and Announced a $50 Price Target
在BTIG将股票从中性上调至买入并宣布50美元的目标股价之后,Outlook Therapeutics的股价走高
Outlook Therapeutics Shares Are Trading Higher After BTIG Upgraded the Stock From Neutral to Buy and Announced a $50 Price Target
在BTIG将股票从中性上调至买入并宣布50美元的目标股价之后,Outlook Therapeutics的股价走高
使用浏览器的分享功能,分享给你的好友吧